CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

FDA Drugs (New Approvals & NDA)
Original article

Over-The-Counter Monograph Drug User Fee Program (OMUFA)

RegulatoryNeutral
AI Analysis

Summary

The FDA discusses a potential user fee program (OMUFA) for over-the-counter monograph drugs as a funding mechanism to supplement congressional appropriations.

Importance:2/10
Sentiment:
0.00
OTCmonographuser feeFDAregulatory

Read the original article

Published by FDA Drugs (New Approvals & NDA) on July 13, 2026 1:58 PM

Read Original